ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2.

Slides:



Advertisements
Similar presentations
European Surveillance of Surgical Site Infections and ICU-acquired Infections, Carl Suetens Surveillance Unit European Centre for Disease Prevention.
Advertisements

European Centre for Disease Prevention and Control
Developing a Framework for Estimation of Healthcare-Associated Infection Burden at the National and State Level Matthew Wise, MPH, PhD Epidemiologist,
Antimicrobial Stewardship: an HAI response activity in Connecticut Richard Melchreit, MD HAI Program Coordinator.
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
Meeting the Challenge of Mandatory HAI Reporting Marcy Maxwell RN, BSN, CIC Dignity Health March 6, 2012.
Completing Ward List (Form A) & determining eligible patients for PPS PPS Data Collector Training April 2012 Presentation 2.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Antimicrobial Use & Case.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
SARS outbreak. SARS Outbreak March 107 MDs and 4 nurses reported sick March 1150 staff screened, 23 admitted, ward closed March 12Clinical teaching suspended.
Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.
STANDARDIZED INFECTION RATIO SIMPLIFIED
QUESTIONS AND ANSWERS. A patient is admitted to the surveillance specialty with a catheter in situ Are they included in CAUTI surveillance?
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
Training Module 2: Respondent Eligibility Criteria.
PPS Data Collector Training April 2012
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,
Erntell M, Skoog G, Cars O, Eriksson M, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P. STRAMA, Swedish Institute.
HCAHPS Hospital Consumer Assessment of Healthcare Providers and Systems.
Indiana Healthcare Associated Infection Initiative Kickoff.
25 January 2013 Dr Ian Arnott UK Inflammatory Bowel Disease (IBD) audit Audit of inpatients with ulcerative colitis 1st January 2013 – 31st December 2013.
1 Health Level Seven (HL7) Report Out Population Science and Structured Documents Workgroup (SDWG) Riki Ohira September 22, 2011.
Improving the quality of medical and surgical care NCEPOD SEPSIS STUDY.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
Mary Andrus, BA, RN, CIC Division of Healthcare Quality Promotion
V. D. Pretlow 1, V.G. Dicks, PhD, MPH 2 1 Georgia Regents University Master of Public Health Program, 2 Georgia Regents University Institute of Public.
Survey Methodology Four Point Scale Very SatisfiedSatisfiedDissatisfiedVery Dissatisfied.
OVERVIEW AND COMPLETING THE QUESTIONNAIRES - Part 1 LECTURE 2.
The NHS Safety Thermometer 10 Steps to Success Series! Step 3 What is the NHS Safety Thermometer?
THE UTI MODULE LECTURE. To outline the aims of the UTI module To describe the questionnaires LECTURE OBJECTIVES.
Version: 1.1 Dated: 04/10/ ,000 Days Campaign Dashboard September 2012 Campaign Manager : Diana Dowdle Clinical Leader: David Grayson Improvement.
Health Care Associated Infections Advisory Panel (HAI) Update Infectious Disease Epidemiology Workgroup June 27, 2008 Austin, Texas Wes Hodgson, MPA Infectious.
Catheter Related Urinary Tract Infections
Ward Name Date Ward Type No. Beds Sister Nurse No. Nurse Name Nurse exp. Patient No. Patient Name Bed No. Date Admitted Date ExpLeave. UNFINF2NF3NF.
Community Acquired Pneumonia (CAP)
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious.
Agents Intervening against Delirium in Intensive Care Unit (AID-ICU): An international inception cohort study AID-ICU Primary investigator: Marie Oxenboell-Collet.
Kupu Taurangi Hauora o Aotearoa. Thank you to all people at the pilot sites who contributed Andrea McCance, Caroline Tilah, Cristina Ross, Fran Grocott,
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2016 Training Day: Lecture 1 Welcome & Introduction to HALT 2016.
NOSOCOMIAL INFECTIons (HOSPITAL ACQUIRED INFECTIONS) by lovella d
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
Yousef I. Aljeesh, PhD, RN Said Abusalem, PhD, RN Naeem Alkariri, MSN, RN John A. Myers, PhD, MSPH Fawwaz Alaloul, PhD, RN Staff Developed IP Program Increases.
ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2.
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2016–2017 Protocol v5.3 Forms.
PPS Data Collector Training April 2017
Søren Marker Jensen, MD, coordinating investigator
CRE prevalence among patients with no prior history of carriage
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2017 Belgian Forms.
Hospital acquired infections
2.13 Copyright UKCS #
Local organisation of the ECDC PPS
Reducing Mortality and Harm
Interpretation of local, national and European level results
ECDC point prevalence survey (PPS)
Data collection methods
Hospital organization, management, and structure for the infection prevention and control of healthcare-associated infection in Chinese hospitals:
Point prevalence survey epidemiology
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Background and Context
* * * * * * * * * Form H: Hospital-based data by surveillance period
Implementing innovation when financial times are hard
Ventilator Associated Pneumonia
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2

European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form N. National/regional data Country Code: _____ Network ID/Data Source: _____ Date start PPS : __ / __ /____ National/regional PPS coordination centre/institute: ________________________________________________ National/regional PPS coordination programme/unit: Name: ____________________________________________ Website: __________________________________________ NYear data Total N of acute care hospitals (“sites”) N of hospital mergers (“trusts”) Total N of beds in acute care hospitals Total N of acute care beds Number of discharges/admissions, all Number of discharges/admissions, acute care beds only Number of patient days, all Number of patient days, acute care beds only Method of sampling/recruitment of hospitals (more than 1 answer possible): O representative systematic random sample O other representative sample O convenience sample (selection) O all hospitals invited O voluntary participation O mandatory participation Total number of hospitals in PPS: Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Number of hospitals submitted to ECDC:Light (unit-based) protocol ____ Standard (patient-based) protocol _____ Comments/observations: __________________________________________________________________________________________ _______________________________________________________________________________________________________________

European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form H. Hospital data Hospital code: Survey dates: From __ / __ /____ To: __ / __ / ____ dd / mm / yyyy dd / mm / yyyy Hospital size (total number of beds) Number of acute care beds Number of ICU beds Exclusion of wards for PPS?  No  Yes, please specify which ward types were excluded: _______________________________________________ Total number of beds in included wards: Total number of patients included in PPS: Hospital Type  Primary  Secondary  Tertiary  Specialized, please specify Specialization type: ______________________ Data apply to:  Single hospital or hospital site  Hospital “trust” or merger PPS Protocol:  Standard  Light Number Year data Incl. wards/ Total (1) Number of discharges/admissions in year Inc Tot Number of patient days in year Alcoholic hand rub consumption liters/yearInc Tot Number of patient rooms in hospital Inc Tot Number of single patient rooms in hospital Number of FTE infection control nurses Inc Tot Number of FTE infection control doctors Comments/observations: ___________________________ ______________________________________________ Is the hospital part of a national representative sample of hospitals ?  No  Yes  Unknown Below: To be filled/checked by national coordinator (1) Data were collected for Included wards only (Inc, = recommended) or for the total hospital (Tot); if all wards were included in PPS (Inc=Tot), mark “Inc”

European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form A. Patient-based data (standard protocol) Antimicrobial (generic or brand name) Route Indication Diagnosis(site)Reason innotes Route: P: parenteral, O: oral, R: rectal, I: inhalation; Indication: CI - LI - HI: treatment intention for community-acquired (CI), long/intermediate-term care-acquired (LI) or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: >1day; MP: medical prophylaxis; O: other; UI: Unknown indication; Diagnosis: see site list, only for treatment intention Reason in notes: Y/N HAI 1HAI 2HAI 3 Case definition code Relevant device in situ before onset (3) O Yes O No O Unknown O Yes O No O Unknown O Yes O No O Unknown Present at admissionO Yes O No Date of onset (4) ___ / ___ / _____ Origin of infection O current hospital O other hospital O other origin/ unk If BSI: source (5) MO-codeR (6) MO-codeR (6) MO-codeR (6) Microorganism 1 Microorganism 2 Microorganism 3 Hospital code Ward name (abbr.)/Unit Id Ward specialty Survey date: ___ / ___ / _______(dd/mm/yyyy) Patient Counter: _________________________________ Age in years: ____ yrs; Age if < 2 year old: _____ months Sex: M F Date of hospital admission: ___ / ___ / _____ Consultant/Patient Specialty: Surgery since admission: O No surgeryO Minimal invasive/non-NHSN surgery O NHSN surgeryO Unknown McCabe score: O Non-fatal disease O Ultimately fatal disease O Rapidly fatal disease O Unknown Central vascular catheter:O No,O Yes O Unk Peripheral vascular catheter:O No O Yes O Unk Urinary catheter: O No O Yes O Unk Intubation:O No O Yes O Unk Patient receives antimicrobial(s) (1) : O No O Yes Patient has active HAI (2) : O No O Yes (3) relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) in 48 hours before onset of infection (even intermittent use), 7 days for UTI; (4) Only for infections not present/active at admission (dd/mm/yyyy); (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK; (6) AMR marker 0,1,2 or 9, see table (1) At the time of the survey, except for surgical prophylaxis 24h before 8:00 AM on the day of the survey; if yes, fill antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30d/1yr), OR discharged from acute care hospital <48h ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill HAI data Patient data (to collect for all patients) IF YES dd / mm / yyyy

European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form B2. Light option: Antimicrobial use and HAI data Hospital code Ward name (abbr.)/Unit Id Patient Counter: _________________________________ Age in years: ____ yrs; Age if < 2 years old: _____ months Sex: M F Date of hospital admission: ___ / ___ / _____ (dd/mm/yyyy) Consultant/Patient Specialty: Patient receives antimicrobial(s) (1) : O No O Yes Patient has active HAI (2) : O No O Yes Antimicrobial (generic or brand name) Route Indication Diagnosis(site)Reason innotes HAI 1HAI 2HAI 3 Case definition code Relevant device in situ before onset (3) O Yes O No O Unknown O Yes O No O Unknown O Yes O No O Unknown Present at admissionO Yes O No Date of onset (4) ___ / ___ / _____ Origin of infection O current hospital O other hospital O other origin/ unk If BSI: source (5) MO-codeR (6) MO-codeR (6) MO-codeR (6) Microorganism 1 Microorganism 2 Microorganism 3 (3) relevant device use (intubation for PN, CVC/PVC for BSI, urinary catheter for UTI) in 48 hours before onset of infection (even intermittent use), 7 days for UTI; (4) Only for infections not present/active at admission (dd/mm/yyyy); (5) C-CVC, C-PVC, S-PUL, S-UTI, S-DIG, S-SSI, S-SST, S-OTH, UO, UNK; (6) AMR marker 0,1,2 or 9, see table (1) At the time of the survey, except for surgical prophylaxis 24h before 8:00 AM on the day of the survey; if yes, fill antimicrobial use data; (2) [infection with onset ≥ Day 3, OR SSI criteria met (surgery in previous 30d/1yr), OR discharged from acute care hospital <48h ago, OR CDI and discharged from acute care hospital < 28 days ago OR onset < Day 3 after invasive device/procedure on D1 or D2] AND [HAI case criteria met on survey day OR patient is receiving (any) treatment for HAI AND case criteria are met between D1 of treatment and survey day]; if yes, fill HAI data IF YES Patient data (patients with HAI and/or antimicrobial only) Route: P: parenteral, O: oral, R: rectal, I: inhalation; Indication: CI - LI - HI: treatment intention for community-acquired (CI), long/intermediate-term care-acquired (LI) or acute hospital-acquired infection (HI); surgical prophylaxis: SP1: single dose, SP2: one day, SP3: >1day; MP: medical prophylaxis; O: other; UI: Unknown indication; Diagnosis: see site list, only for treatment intention Reason in notes: Y/N

European Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use Form B1. Light option: Ward denominator data Survey date 1 : ___ / ___ / _______ Hospital code dd / mm / yyyy Ward name (abbr.) /Unit Id Ward specialty 2 Total number of patients in ward 3 Number of patients by consultant/patient specialty: Consultant/patient SpecialtyNumber of patients in ward 3 1 Patients on the same ward should be included on a single day if possible 2 Main ward specialty: >=80% of patients belong to this specialty, otherwise choose mixed ward 3 Admitted to the ward before or at 8:00 AM and not discharged from the ward at time of the survey